An overview of the role of T cells in controlling tuberculosis infection in a pediatric population

Journal of Pediatric Infectious Diseases

Volumn 4, Issue 3, 2009, Pages 221-228

  Di Carlo, Paola ^a,d   Romano, Amelia ^b   Melis, Mario ^c   Abbagnato, Luisa ^a   Caccamo, Nadia ^a   Meraviglia, Serena ^a   Dieli, Francesco ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ospedale dei Bambini G Di Cristina   (Italy)

^c CNR   (Italy)

^d Dipartimento di Biopatologia e Metodologie Biomediche ^*  (Italy)

Author keywords

Children; Immune response; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GRANULYSIN; INTERLEUKIN 2; ISONIAZID; LIPOCORTIN 5; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PYRAZINAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC RESISTANCE; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; INFECTION CONTROL; LEUKOCYTE AGGREGATION; LYMPHOCYTE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PEDIATRICS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VGAMMA9 VDELTA2 T LYMPHOCYTE;

EID: 68349148094     PISSN: 13057707     EISSN: None     Source Type: Journal    
DOI: 10.3233/JPI-2009-0178     Document Type: Review

References (79)

1. WHO 2008. Global tuberculosis control: Surveillance, planning, financing. WHOreport 2008, WHO/HTM/TB/2007.376 ed. World Health Organization.
2. J.R. Starke, Tuberculosis, in: Infectious Diseases of Children, S.L. Katz, A.A. Gershon and P.J. Hotez, eds, St.Louis: Mosby, 1998, pp. 571-604.
3. S.M. Newton, A.J. Brent, S. Anderson, E. Whittaker and B. Kampmann, Paediatric tuberculosis, Lancet Infect Dis 8 (2008), 498-510.
4. J.L. Flynn and J. Chan, Immunology of tuberculosis, Annu Rev Immunol 19 (2001), 93-129.
5. J.L. Flynn, M.M. Goldstein, K.J. Triebold, B. Koller and B.R. Bloom, Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacteriumtuberculosis infection, Proc Natl Acad Sci USA 89 (1992), 12013-12017.
6. P. Eamranond and E. Jaramillo, Tuberculosis in children: Re-assessing the need for improved diagnosis in global control strategies, Int J Tuberc Lung Dis 5 (2001), 594-603.
7. J.R. Starke, Pediatric tuberculosis: Time for a new approach, Tuberculosis (Edinb) 83 (2003), 208-212.
8. M. Curto, C. Reali, G. Palmieri et al., Inhibition of cytokines expression in human microglia infected by virulent and non-virulent mycobacteria, Neurochem Int 44 (2004), 381-392.
9. L.E. Bermudez and F.J. Sangari, Cellular and molecular mechanisms of internalization of mycobacteria by host cells, Microbes Infect 3 (2001), 37-42.
10. B.J. Marais, R.P. Gie, A.C. Hesseling et al., A refined symptom-based approach to diagnose pulmonary tuberculosis in children, Pediatrics 118 (2006), e1350-e1359.
11. C.M. Osborne, The challenge of diagnosing childhood tuberculosis in a developing country, Arch Dis Child 72 (1995), 369-374.
12. M. Pai, L.W. Riley and J.M. Colford, Jr., Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review, Lancet Infect Dis 4 (2004), 761-776.
13. M. Pai, K. Dheda, J. Cunningham, F. Scano and R. O'Brien, T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward, Lancet Infect Dis 7 (2007), 428-438.
14. A. Lalvani, Diagnosing tuberculosis infection in the 21st century: New tools to tackle an old enemy, Chest 131 (2007), 1898-1906.
15. K. Dheda, Z.F. Udwadia, J.F. Huggett, M.A. Johnson and G.A. Rook, Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis, Curr Opin Pulm Med 11 (2005), 195-202.
16. D. Goletti, S. Carrara, H. Mayanja-Kizza and J. Baseke, Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: A pilot study, BMC Infect Dis 8 (2008), 2334-2338.
17. Department of Health Welsh Office Scottish Office, Department of Health DHSS (Northern Ireland). Tuberculosis: BCG Immunization, in: Immunization Against Infectious Disease, (2nd ed.), D. Salisbury and N. Begg, eds, London: HMSO, 1996, pp. 231-232.
18. N.E. Aronson, M. Santosham, G.W. Comstock et al., Longterm efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study, JAMA 291 (2004), 2086-2091.
19. A.R. Bennett, P. Gorak-Stolinska, A. Ben-Smith et al., The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: A new repertoire evolves over 12 months, Vaccine 24 (2006), 2617-2626.
20. R.E. Weir, P. Gorak-Stolinska, S. Floyd et al., Persistence of the immune response induced by BCG vaccination, BMC Infect Dis 25 (2008), 8-9.
21. R.S. Rosada, L.G. de la Torre, F.G. Frantz et al., Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes, BMC Immunol 9 (2008), 2172-2179.
22. W.H. Boom, The role of T-cell subsets in Mycobacterium tuberculosis infection, Infect Agents Dis 5 (1996), 73-81.
23. S. Stenger and R.L. Modlin, T cell mediated immunity to Mycobacterium tuberculosis, Curr Opin Microbiol 2 (1999), 89-93.
24. C.H. Ladel, C. Blum, A. Dreher, K. Reifenberg and S.H. Kaufmann, Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis, Eur J Immunol 25 (1995), 2877-2881.
25. D.S. Kumararatne, A.S. Pithie, P. Drysdale et al., Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis, Clin Exp Immunol 80 (1990), 314-323.
26. W.H. Boom, R.S. Wallis and K.A. Chervenak, Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: Heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes, Infect Immun 59 (1991), 2737-2743.
27. D.P. Chin and P.C. Hopewell, Mycobacterial complications of HIV infection, Clin Chest Med 17 (1996), 697-711.
28. S. Swaminathan, Tuberculosis in HIV-infected children, Paediatr Respir Rev 5 (2004), 225-230.
29. W.A. Hanekom, The immune response to BCG vaccination of newborns, Ann N Y Acad Sci 1062 (2005), 69-78.
30. A.M. Caruso, N. Serbina, E. Klein et al., Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis, J Immunol 162 (1999), 5407-5416.
31. M.C. Sasiain, S. de la Barrera, S. Fink et al., Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD, Clin Exp Immunol 114 (1998), 196-203.
32. L. Walker and D.B. Lowrie, Killing of Mycobacterium microti by immunologically activated macrophages, Nature 293 (1981), 69-71.
33. I.E. Flesch and S.H. Kaufmann, Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor, Infect Immun 58 (1990), 2675-2677.
34. A. Muotiala and P.H. Mäkelä, The role of IFN-gamma in murine Salmonella typhimurium infection, Microb Pathog 8 (1990), 135-141.
35. A.P. Soares, T.J. Scriba, S. Joseph et al., Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles, J Immunol 180 (2008), 3569-3577.
36. S.C. Cowley and K.L. Elkins, CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo, J Immunol 171 (2003), 4689-4699.
37. M.J. Newport, C.M. Huxley, S. Huston et al., A mutation in the interferon-gamma-receptor gene and susceptibility to disseminated mycobacterial infection, N Engl J Med 335 (1996), 1941-1949.
38. S.M. Vidal, D. Malo, K. Vogan, E. Skamene and P. Gros, Natural resistance to infection with intracellular parasites: Isolation of a candidate for BCG, Cell 73 (1993), 469-485.
39. J.H. Huang, P.J. Oefner, V. Adi et al., Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease, Am J Respir Crit Care Med 157 (1998), 377-381.
40. G. Tanaka, J. Shojima, I. Matsushita et al., Pulmonary Mycobacterium avium complex infection: Association with NRAMP1 polymorphisms, Eur Respir J 30 (2007), 90-96.
41. K. Tsukaguchi, B. de Lange and W.H. Boom, Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alpha beta T-cell receptor + T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra, Cell Immunol 194 (1999), 12-20.
42. D.R. Roach, A.G. Bean, C. Demangel, M.P. France, H. Briscoe and W.J. Britton, TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection, J Immunol 168 (2002), 4620-4627.
43. D. Smith, H. Hänsch, G. Bancroft and S. Ehlers, T-cell-independent granuloma formation in response to Mycobacterium avium: Role of tumour necrosis factor-alpha and interferon-gamma, Immunology 92 (1997), 413-421.
44. P.L. Lin, H.L. Plessner, N.N. Voitenok and J.L. Flynn, Tumor necrosis factor and tuberculosis, J Investig Dermatol Symp Proc 12 (2007), 22-25.
45. C.H. Ladel, S. Daugelat and S.H. Kaufmann, Immune response to Mycobacterium bovis bacille Calmette Gúerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance, Eur J Immunol 25 (1995), 377-384
46. A.O. Sousa, R.J. Mazzaccaro, R.G. Russell et al., Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice, Proc Natl Acad Sci USA 97 (2000), 4204-4208.
47. S.M. Smith and H.M. Dockrell, Role of CD8 T cells in mycobacterial infections, Immunol Cell Biol 78 (2000), 325-333.
48. S. Stenger, Da. Hanson, R. Teitelbaum et al., An antimicrobial activity of cytolytic T cells mediate by granulysin, Science 282 (1998), 121-125.
49. S. Thoma-Uszynski, S. Stenger and R.L. Modlin, CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis, J Immunol 165 (2000), 5773-5779.
50. S. Stenger, R.J. Mazzaccaro, K. Uyemura et al., Differential effects of cytolytic T cell subsets on intracellular infection, Science 276 (1997), 1684-1687.
51. P.A. Henkart, M.S. Williams, C.M. Zacharchuk and A. Sarin, Do CTL kill target cells by inducing apoptosis? Semin, Immunol 9 (1997 , 135-144.
52. M.B. Santucci, M. Amicosante, R. Cicconi et al., Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: Early membrane modifications and intracellular mycobacterial viability, J Infect Dis 181 (2000), 1506-1509.
53. G.M. Cohen, Caspases: The executioners of apoptosis, Biochem J 326 (1997), 1-16.
54. K. Klingler, K.M. Tchou-Wong, O. Brändli et al., Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes, Infect Immun 65 (1997), 5272-5278.
55. S. Thoma-Uszynski, S. Stenger and R.L. Modlin, CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis, J Immunol 165 (2000), 5773-5779.
56. J. Keane, M.K. Balcewicz-Sablinska, H.G. Remold et al., Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis, Infect Immun 65 (1997), 298-304.
57. M.K. Balcewicz-Sablinska, J. Keane, H. Hornfeld and H.G. Remold, Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by realiste of TNF-R2, resulting in inactivation of TNF-alpha, J Immunol 161 (1998), 2636-2641.
58. V. Briken and J.L. Miller, Living on the edge: Inhibition of host cell apoptosis by Mycobacterium tuberculosis, Future Microbiol 3 (2008), 415-422.
59. M.R. Melis, E. Pace, P. Di Carlo et al., Increased peripheral T-Lymphocyte apoptosis in Childhood tuberculosis. 98th International Conference of the American Thoracic Society, May 17-22, 2002; Atlanta, Georgia, Am J Respir Crit Care Med 165(8 Suppl) (2002), A289.
60. CDC, Case definitions for infectious conditions under public health surveillance 1997, MMWR 46(No. RR-10), 40-41.
61. M. Melis, L. Siena, E. Pace et al., Fluticasone induces apoptosis in peripheral T-lymphocytes: A comparison between asthmatic and normal subjects, Eur Respir J 19 (2002), 257-266.
62. S.V. Pena and A.M. Krensky, Granulysin. A new human cytolytic granule-associated protein with possible involvement in cell mediated cytotoxicity, Semin Immunol 9 (1997), 117-125.
63. J. Kumar, S. Okada, C. Clayberger and A.M. Krensky, Granulysin: A novel antimicrobial, Expert Opin Investig Drugs 10 (2001), 321-329.
64. D.A. Hanson, A.A. Kaspar, F.R. Poulain and A.M. Krensky, Biosynthesis of granulysin, a novel cytolytic molecule, Mol Immunol 36 (1999), 413-422.
65. F. Dieli, M. Troye-Blomberg, J. Ivanyi et al., Granulysin dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vg9Vd2 T lymphocytes, J Infect Dis 184 (2001), 1082-1085.
66. J.L. Gansert, V. Kiessler, M. Engele et al., Human NKT cells express granulysin and exhibit antimycobacterial activity, J Immunol 170 (2003), 3154-3161.
67. D. Di Liberto, S. Buccheri, N. Caccamo et al., Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy, Tuberculosis (Edinb) 87 (2007), 322-328.
68. W.K. Born, R.L. O'Brien and R.L. Modlin, Antigen-specificity of gamma delta T lymphocytes, FASEB J 5 (1991), 2699-2705.
69. T. Inoue, Y. Yoshikai, G. Matsuzaki and K. Nomoto, Early appearing gamma/ delta-bearing T cells during infection with Calmétte Guérin bacillus, J Immunol 146 (1991), 2754-2762.
70. G. Panchamoorthy, J. McLean, R.L. Modlin et al., A predominance of the Vg2/d2 subset in human mycobacteria-responsive T cells suggests germ line gene encoded recognition, J Immunol 147 (1991), 3360-3369.
71. K. Pechhold, D. Wesch, S. Schondelmaier and D. Kabelitz, Primary activation of V gamma 9-expressing gamma delta T cells by Mycobacterium tuberculosis. Requirement for Th1-type CD4 T cell help and inhibition by IL-10, J Immunol 152 (1994), 4984-4991.
72. C.T. Morita, E.M. Beckman, J.F. Bukowski et al., Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells, Immunity 3 (1995), 495-507.
73. C.M. Parker, V. Groh, H. Band et al., Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire, J Exp Med 171 (1990), 1597-1612.
74. F. Dieli, G. Sireci, C. Di Sano et al., Ligand-specific alphabeta and gammadelta T cell responses in childhood tuberculosis, J Infect Dis 181 (2000), 294-301.
75. F. Dieli, G. Sireci, C. Di Sano, E. Champagne, J.J. Fourniè and J.I. Salerno, Predominance of Vgamma9/Vdelta2 T lymphocytes in the cerebrospinal fluid of children with tuberculous meningitis: Reversal after chemotherapy, Mol Med 5 (1999), 301-312.
76. F. Dieli, G. Sireci, N. Caccamo et al., Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis, J Infect Dis 186 (2002), 1835-1839.
77. D. Wesch, D. Kabelitz, K. Friese and K. Pechhold, Mycobacteria-reactive γδT cells in HIV-infected individuals: Lack of V gamma 9 cells responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells, Eur J Immunol 26 (1996), 557-562.
78. F. Dieli, M. Troye-Blomberg, J. Ivanyi et al., Vg9/Vd2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis, Eur J Immunol 30 (2000), 1512-1519.
79. N. Caccamo, S. Meraviglia, C. La Mendola, G. Guggino, F. Dieli and A. Salerno, Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens, J Immunol 177 (2006), 1780-1785.